Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

MEDLEY PHARMS

  • FDA Approval
  • April 04, 2024, 08:49 UTC
  • 35
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • April 04, 2024, 08:49 UTC
  • 41
  • 0 comments

FDA approve BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • April 04, 2024, 08:49 UTC
  • 36
  • 0 comments

FDA approve DEXTROAMPHETAMINE SULFATE

Comment Full text

SUN PHARM INDUSTRIES

  • FDA Approval
  • April 04, 2024, 08:49 UTC
  • 41
  • 0 comments

FDA approve AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Comment Full text

ZYDUS LIFESCIENCES

  • FDA Approval
  • April 04, 2024, 08:49 UTC
  • 40
  • 0 comments

FDA approve CANDESARTAN CILEXETIL

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • April 04, 2024, 08:49 UTC
  • 40
  • 0 comments

FDA approve ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Comment Full text

ALEMBIC

  • FDA Approval
  • April 04, 2024, 08:49 UTC
  • 35
  • 0 comments

FDA approve CLINDAMYCIN PHOSPHATE

Comment Full text

PHARMAMAX

  • FDA Approval
  • April 04, 2024, 08:49 UTC
  • 37
  • 0 comments

FDA approve ARFORMOTEROL TARTRATE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • April 04, 2024, 08:39 UTC
  • 40
  • 0 comments

FDA approve VORTIOXETINE HYDROBROMIDE

Comment Full text

SABA ILAC SANAYIVE

  • FDA Approval
  • April 04, 2024, 04:34 UTC
  • 43
  • 0 comments

FDA approve FUROSEMIDE

Comment Full text
  • Previous
  • 485
  • 486
  • 487
  • 488
  • 489
  • Next

Search

News categories

  • Technical Exchange News(11746)
  • Event(4165)
  • SEC News(233374)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(142859)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin